Loading…
Anbio Biotechnology is projected to decline to $9.59 by 2027, a -3% move from its current price of $9.90. NNNN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $9.38 | $9.91 | $10.47 | +0.10% |
| Aug 4 | $9.18 | $9.92 | $10.72 | +0.19% |
| Aug 5 | $9.03 | $9.93 | $10.92 | +0.29% |
| Aug 6 | $8.91 | $9.94 | $11.09 | +0.38% |
| Aug 7 | $8.80 | $9.95 | $11.24 | +0.48% |
| Aug 8 | $8.71 | $9.96 | $11.39 | +0.58% |
| Aug 9 | $8.62 | $9.97 | $11.52 | +0.67% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $8.62 | $9.97 | $11.52 | +0.67% |
| Week 2 | $8.17 | $10.03 | $12.32 | +1.35% |
| Week 3 | $7.86 | $10.10 | $12.99 | +2.04% |
| Week 4 | $7.61 | $10.17 | $13.59 | +2.73% |
| Week 5 | $7.40 | $10.24 | $14.16 | +3.42% |
| Week 6 | $7.23 | $10.31 | $14.70 | +4.12% |
| Week 7 | $7.07 | $10.38 | $15.23 | +4.82% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Anbio Biotechnology provides in vitro diagnostics (IVD) products across the European Union, the Asia Pacific, North America, South America, and internationally. Its product lines include lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets.
Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.
Anbio Biotechnology (NNNN) is currently priced at $10.75 with a market capitalization of $471.83M. It is ranked 2892 in market cap among listed assets. The current price sits within a forecast where the 2026 average is $10.75 with a range from $9.12 to $16.11 (0% ROI) and NEUTRAL sentiment.
Looking further ahead, the multi-year forecast turns bullish from 2031 onward, with average prices rising toward $14.92 in 2031, $17.14 in 2032, and up to $49.65 in 2050, delivering ROIs from 38.8% in 2031 to 361.8% by 2050.
A major floor 55.9% below — a decisive break under it would weaken the trend.
The nearest floor, 7.9% below — buyers have tended to step in here.
The nearest ceiling, 68.1% above — a clean break opens room to run.
A major ceiling 247.9% above — clearing it would confirm fresh momentum.
Key NNNN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NNNN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.51 | Sell | $10.36 | Sell |
| MA 10 | $10.07 | Sell | $10.31 | Sell |
| MA 20 | $10.21 | Sell | $11.11 | Sell |
| MA 50 | $17.04 | Sell | $15.26 | Sell |
| MA 100 | $21.44 | Sell | $19.43 | Sell |
| MA 200 | $24.30 | Sell | $22.33 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 36.38 | Neutral |
| Stoch RSI (14) | 59.86 | Neutral |
| CCI (20) | -27.48 | Neutral |
| Williams %R (14) | -68.42 | Info |
| MACD (12,26,9) | 0.56 | Buy |
| ROC (12) | 8.55 | Buy |
| Bollinger %B (20,2) | 0.41 | Neutral |
| Stochastic %K (14) | 31.58 | Neutral |
| TRIX (15) | -2.24 | Sell |
| Awesome (5,34) | -1.71 | Sell |
| Ultimate (7,14,28) | 50.15 | Neutral |
| Momentum (10) | 0.41 | Buy |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 10.97 | Sell |
| ADX (14) | 37.27 | Sell |
| ATR (14) | 0.62 | Info |
The 30-day technical picture is NEUTRAL. RSI14 is 40, and the price remains below the 50-day and 200-day simple moving averages (SMA50 $17.49; SMA200 $24.39). The 30-day range runs from $7.54 to $15.32, with a support level at $9.12 and a resistance at $16.64. Volatility is high, with annualized volatility of 100% and overall sentiment labeled NEUTRAL.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $9.12 | $9.90 | $14.82 | 0% | Neutral | |
| $6.98 | $9.59 | $14.25 | -3% | Neutral | |
| $6.69 | $9.79 | $15.52 | -1% | Neutral | |
| $6.46 | $9.96 | $16.59 | +1% | Neutral | |
| $6.02 | $9.73 | $16.89 | -2% | Neutral | |
| $7.76 | $13.13 | $23.59 | +33% | Bullish | |
| $8.62 | $15.21 | $28.18 | +54% | Bullish | |
| $8.41 | $15.47 | $29.47 | +56% | Bullish | |
| $7.40 | $14.16 | $27.66 | +43% | Bullish | |
| $6.37 | $12.67 | $25.32 | +28% | Bullish | |
| $8.93 | $19.84 | $43.64 | +100% | Bullish | |
| $19.02 | $42.26 | $97.21 | +327% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $9.12 | $9.90 | $13.09 | +0.00% |
| September 2026 | $9.14 | $11.12 | $14.15 | +12.37% |
| October 2026 | $8.75 | $10.81 | $14.02 | -2.86% |
| November 2026 | $8.53 | $10.65 | $14.04 | -1.45% |
| December 2026 | $8.79 | $11.09 | $14.82 | +4.11% |
Click any year to see its month-by-month NNNN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The NNNN price prediction for 2026 points to an average of $9.90 (low $9.12, high $14.82) — a potential gain of 0% on today's $9.90. A consolidation phase looks the most probable path here.
In 2027, NNNN is projected to trade between $6.98 and $14.25, averaging $9.59 — a potential decline of -3% from today's $9.90. That is -3% versus the projected 2026 average. Price action looks broadly range-bound.
Anbio Biotechnology's 2028 outlook centres on $9.79, within a $6.69 to $15.52 range. That is up +2% on the projected 2027 average. That marks a -1% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, NNNN could reach as high as $16.59, with a base case around $9.96 and support toward $6.46 — roughly +1% from $9.90. Price action looks broadly range-bound.
Expect NNNN to range from $6.02 to $16.89 through 2030. The $9.73 average target implies a -2% move from current prices. That is -2% versus the projected 2029 average. A consolidation phase looks the most probable path here.
The NNNN price prediction for 2031 points to an average of $13.13 (low $7.76, high $23.59) — a potential gain of +33% on today's $9.90. Momentum favours further upside here.
In 2032, NNNN is projected to trade between $8.62 and $28.18, averaging $15.21 — a potential gain of +54% from today's $9.90. That is up +16% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Anbio Biotechnology's 2033 outlook centres on $15.47, within a $8.41 to $29.47 range. That is up +2% on the projected 2032 average. That marks a +56% change versus current levels. Momentum favours further upside here.
By 2034, NNNN could reach as high as $27.66, with a base case around $14.16 and support toward $7.40 — roughly +43% from $9.90. Buyers look set to stay in control over this stretch.
Expect NNNN to range from $6.37 to $25.32 through 2035. The $12.67 average target implies a +28% move from current prices. That is -11% versus the projected 2034 average. Momentum favours further upside here.
The NNNN price prediction for 2040 points to an average of $19.84 (low $8.93, high $43.64) — a potential gain of +100% on today's $9.90. Buyers look set to stay in control over this stretch.
In 2050, NNNN is projected to trade between $19.02 and $97.21, averaging $42.26 — a potential gain of +327% from today's $9.90. That is up +113% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in NNNN today (≈ 101.010101 NNNN) could be worth
$4,269.1
+$3,269.1 (+327%) by 2050 · US Dollar
Based on the average projected NNNN price of $42.26 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NNNNwould be worth at today's price.
$1,000 invested in NNNN on Jul 31, 2025 (≈ 22.436617 NNNN) would be worth
$222.12
-$777.88 (-77.8%) today · 0.22× · US Dollar
Based on a NNNN entry price of $44.57 vs. today's $9.9.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $9.9 | $1,000 | +0.0% |
| 1 month ago | $12.35 | $801.94 | -19.8% |
| 3 months ago | $28.9 | $342.56 | -65.7% |
| 6 months ago | $24.66 | $401.46 | -59.9% |
| 1 year ago | $44.57 | $222.12 | -77.8% |
| All time (1.4y) ago | $5.77 | $1,715.77 | +71.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NNNN forecast.
Our base-case forecast reaches $20.00 around 2050.
Implied market cap at $20.00: $877.82M
The year-by-year forecast shows a neutral stance in 2026 (avg $10.75; min $9.12; max $16.11; ROI 0; NEUTRAL) and a slight dip in 2027 (avg $10.47; min $7.61; max $15.56; ROI -2.6; NEUTRAL), followed by a gradual recovery into 2028 (avg $10.79; min $7.37; max $17.13; ROI 0.4) and 2029 (avg $11.10; min $7.19; max $18.51; ROI 3.3) and 2030 (avg $11.02; min $6.81; max $19.14; ROI 2.5). Beginning in 2031 the forecast shifts to BULLISH, with avg prices of $14.92 (ROI 38.8) and rising to $17.14 (ROI 59.5) in 2032 and $17.36 (ROI 61.5) in 2033, then $16.02 (ROI 49) in 2034 and $14.46 (ROI 34.5) in 2035. The bullish arc continues into 2040 (avg $22.81; min $10.26; max $50.22; ROI 112.2) and culminates in 2050 (avg $49.65; min $22.34; max $114.18; ROI 361.8).
These are estimates, not guarantees, and reflect a path of rising averages and substantial upside alongside inherent market volatility.
Tap a question to reveal the answer.
Average price $11.02; min $6.81; max $19.14; ROI 2.5%; sentiment NEUTRAL.
Short-term 2026 forecast is NEUTRAL with avg $10.75 and ROI 0. From 2031 onward the outlook is BULLISH, with rising averages and ROIs (e.g., 2031 ROI 38.8% and 2050 ROI 361.8%), but 2027 shows a potential negative ROI of -2.6%.
Yes, the 2040 forecast shows a max of $50.22 with an average of $22.81 and ROI 112.2, in a bullish multi-year trajectory that continues to 2050 (max $114.18; ROI 361.8).
Current price $10.75; Market cap $471.83M; Rank 2892.
30-day range is $7.54 to $15.32; RSI 14 is 40; SMA50 is $17.49; SMA200 is $24.39; support $9.12; resistance $16.64; sentiment NEUTRAL; annualized volatility 100%.
Anbio Biotechnology Community Discussion
0Share your Anbio Biotechnology price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.